Quarterly Reports

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

Quarterly Reports

Date	Form	Description	Pages
11/14/23	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	34
08/14/23	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.4 EX-31.1 EX-31.2 EX-32.1 EX-32.2	43
05/15/23	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	34
11/14/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	40
08/15/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-3.9 EX-31.1 EX-31.2 EX-32.1 EX-32.2	40
05/16/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	35
11/15/21	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	35
08/16/21	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	34
05/13/21	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	30
11/06/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	32